Riikka Havunen

Riikka Havunen

Company: TILT Biotherapeutics

Job title: Head of Research And Development

Seminars:

Clinical TIL Treatment: Addressing the Combination, Order & Impact of Therapeutic Approaches Q&A + Open Counsel 12:30 pm

Read more

day: Conference Day

TILT -123 in Phase 1 Clinical Trials. Concurrent TIL & Oncolytic Viral Therapy. 11:40 am

Interpreting current clinical evidence and extrapolating the benefits Describing mechanistic action of oncolytic virus Considering changes in the tumor microenvironment and TIL response from viral treatmentRead more

day: Conference Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.